New Search

If you are not happy with the results below please do another search

1123 search results for:

543

Ellutia releases fully automated total nitrosamine testing system

Ellutia is releasing its newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and sensitivity, so it can quickly identify whether or not nitrosamines are present down to 1ppb levels.

544

Waters automates solid phase extraction of biological, food and environmental samples with Andrew+ Pipetting Robot

Waters Corporation has introduced their Extraction+ Connected Device, a new software-controlled product for the Waters Andrew+ Pipetting Robot that automates the preparation of biological, food, forensics and environmental samples by solid phase extraction (SPE). The Extraction+ Connected Device eliminates the need to manually pipette and extract samples with a hands-free, automated approach to SPE. It […]

545

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]

547

Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.

549

Greiner Bio-One achieves good results with sustain­ability assessment

Greiner Bio-One had its sustainability efforts evaluated for the first time for the entire Group through the EcoVadis platform and was awarded the silver medal for its commitment. The Greiner Bio-One Group achieved 60 out of 100 points. With this overall rating, the company group ranks among the top 20% of all companies evaluated. Greiner […]

550

Sphere Fluidics opens new lab facilities at Granta Park, UK

Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.